Renaissance Technologies’s Omega Protein OME Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-417,055
| Closed | -$6.94M | – | 3619 |
|
|
2017
Q3 | $6.94M | Buy |
417,055
+54,755
| +15% | +$890K | 0.01% | 1547 |
|
|
2017
Q2 | $6.49M | Buy |
362,300
+39,874
| +12% | +$745K | 0.01% | 1534 |
|
|
2017
Q1 | $6.46M | Buy |
322,426
+74,526
| +30% | +$1.74M | 0.01% | 1522 |
|
|
2016
Q4 | $6.21M | Buy |
247,900
+114,400
| +86% | +$2.7M | 0.01% | 1529 |
|
|
2016
Q3 | $3.12M | Buy |
+133,500
| New | +$3.14M | 0.01% | 1925 |
|
|
2016
Q1 | – | Sell |
-31,200
| Closed | -$693K | – | 3649 |
|
|
2015
Q4 | $693K | Sell |
31,200
-61,800
| -66% | -$1.29M | ﹤0.01% | 2610 |
|
|
2015
Q3 | $1.58M | Buy |
93,000
+22,800
| +32% | +$355K | ﹤0.01% | 2134 |
|
|
2015
Q2 | $965K | Buy |
70,200
+21,200
| +43% | +$282K | ﹤0.01% | 2473 |
|
|
2015
Q1 | $671K | Sell |
49,000
-16,100
| -25% | -$186K | ﹤0.01% | 2494 |
|
|
2014
Q4 | $688K | Sell |
65,100
-101,800
| -61% | -$1.21M | ﹤0.01% | 2318 |
|
|
2014
Q3 | $2.09M | Sell |
166,900
-5,100
| -3% | -$71.1K | 0.01% | 1655 |
|
|
2014
Q2 | $2.35M | Sell |
172,000
-17,526
| -9% | -$229K | 0.01% | 1645 |
|
|
2014
Q1 | $2.29M | Sell |
189,526
-10,574
| -5% | -$121K | 0.01% | 1695 |
|
|
2013
Q4 | $2.46M | Buy |
200,100
+108,500
| +118% | +$1.27M | 0.01% | 1642 |
|
|
2013
Q3 | $932K | Sell |
91,600
-108,800
| -54% | -$1.02M | ﹤0.01% | 2045 |
|
|
2013
Q2 | $1.8M | Buy |
+200,400
| New | +$2.02M | ﹤0.01% | 1636 |
|
Renaissance Technologies's OME Position: Q4 2017 in Review
Renaissance Technologies sold out of Omega Protein (OME) in Q4 2017, closing a stake of 417,055 shares — an estimated $6.94M sold.
Renaissance Technologies first reported a position in OME in Q2 2013 and held it in 16 quarters. The position peaked at $6.94M in Q3 2017. 0 funds tracked by Wall St. Rank hold OME as of Q4 2017.
- Renaissance Technologies reported no remaining Omega Protein position as of Q4 2017 after selling out during the quarter.
- Renaissance Technologies sold 417,055 Omega Protein shares in Q4 2017, an estimated $6.94M.
- Renaissance Technologies first reported a position in Omega Protein in Q2 2013 and held it in 16 quarters.
- Renaissance Technologies's Omega Protein position peaked at $6.94M in Q3 2017.
- 0 funds tracked by Wall St. Rank held Omega Protein as of Q4 2017.
Based on Renaissance Technologies's 13F filing for Q4 2017, filed 13 Feb 2018.